This leadership transition is anticipated to further Akari’s momentum in developing transformative cancer ... aims to advance Akari’s novel spliceosome inhibitor payload ADC technology and ...

Announced Positive Outcome of Interim Analysis for its Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML) with ...

This leadership transition is anticipated to further Akari’s momentum in developing transformative cancer treatments.Want deeper insights ... The private placement aims to advance Akari’s novel ...

Proper splicing requires efficient spliceosome assembly ... A mechanistic study reveals that RBPMS suppresses bladder cancer cell migration by regulating alternative splicing of ANKRD10, which ...

Announced Positive Outcome of Interim Analysis for its Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML) with Next and Final Analysis Planned Upon Reaching 80 Events ...

Metabolic reprogramming in cancer cells could be impacted by post-translational events and epigenetic regulation of genes. RALY was identified in the spliceosome complex and in the Drosha ...

Scientists at the UCLA Health Jonsson Comprehensive Cancer Center and the University of Toronto have revealed how a tiny ...

Drugs and other treatments can be quite effective at killing cancer cells, yet many fall short as they struggle to penetrate ...

Despite the high incidence of brain metastasis after resection of non-small cell lung cancer (NSCLC), the National Comprehensive Cancer Network guidelines do not recommend central nervous system (CNS) ...

As AstraZeneca awaits an FDA decision for its Daiichi Sankyo-partnered Datroway in EGFR-mutated non-small cell lung cancer ...

NYU scientists have discovered that cancer cells work together to withstand challenging conditions, revealing new ...